Business Wire

Prominent Coalition of World Class International and Danish Law Firms and ISAF Management Company Proceed with Investor Lawsuit against Danske Bank

Share

International Securities Associations and Foundations Management Company (“ISAF”) announces the formation of an international coalition of leading American, German and Dutch law firms and the appointment of the preeminent Danish law firm, Németh Sigetty, to proceed with a lawsuit against Danske Bank A/S (“Danske” or the “Bank”) to pursue compensation for damaged investors after revelations of money laundering, financial mismanagement and deficient regulatory disclosures.

The lawsuit will be filed in Copenhagen, Denmark on behalf of investors who suffered investment losses in Danske’s share price after various disclosures related to an estimated EUR €200 billion money transfer scheme involving non-resident Eastern European and Russian customers in the Bank’s Estonian Branch. Information about critical lapses in Danske’s ‘know your customer’ and anti-money laundering internal enforcement policies, and its failure to act upon both internal and external warnings of non-compliance, caused a more than a 40% decline in Danske’s stock price resulting in losses for investors measured in tens of billions of Danish kroner (billions of US dollars).

Some of the world’s leading law firms, including the US-based law firm Pomerantz LLP, that recently secured a USD $3 billion investor settlement from Petrobras in the US; the US-based law firm Lieff Cabraser Heimann & Bernstein, LLP that has litigated and resolved some of the most important complex civil and securities litigations in recent history, including the recent USD $15 billion civil settlement with Volkswagen on behalf of American diesel vehicle owners and lessees; the German law firm, TILP Litigation Rechtsanwaltsgesellschaft mbH, the lead counsel in the Euro €10 billion collective international investor claim action against Volkswagen in Germany; and the Dutch law firm, Lemstra Van der Korst N.V., that represents a foundation for damaged investors in Petrobras having billions of US dollars and euros in losses in Petrobras, as well as similar foundations for Libor rate rigging and other matters. The coalition is working together with Danish law firm Németh Sigetty to bring justice to investors who lost as much as USD $15 billion, as a result of revelations of Danske’s money laundering scheme, financial mismanagement and deficient regulatory disclosures.

ISAF is an investor protection interest company. ISAF provides administration and organizes the collection of client trading data, investor loss calculations and certification, investor related litigation documentation and full funding for the group litigation.

In terms of Collective Investor Actions, Denmark is an opt-in jurisdiction. The process to recover losses requires damaged investors to proactively join an organized litigation “Group” which will aggregate each investor’s loss into a collective loss in a single claim and action before the Danish Court. Németh Sigetty will file this Group litigation on behalf of the eligible investors organized via the ISAF coalition in the coming months. Group litigation, such as the litigation against Danske Bank, is a costly proposition in Denmark.

The investors joining the ISAF coalition litigation in Denmark do not have to pay any upfront or running costs during this litigation, including: any legal fees, court fees, potential counter-party legal cost risk guarantees, claims analysis costs or administration costs. If the litigation results in a financial settlement or judgment for damaged investors, the ISAF coalition will only collect a percentage-based success fee at the very end of the process.

Investors who own or have owned shares of Danske Bank on the Copenhagen Stock Exchange (Nasdaq Copenhagen) between 2007-2018 and suffered losses after the revelations in 2017 and 2018 of the critical deficiencies in Danske Bank’s anti-money laundering protocols and procedures are eligible to pursue compensation via this ISAF-sponsored Group litigation in Denmark.

The coalition includes:

Law Firms:

  • Németh Sigetty – The lawyers at Németh Sigetty have a well-deserved reputation for handling major, complex, and high-stakes disputes against both private party litigants and government authorities and have vast experience with investor group litigations in Denmark. Németh Sigetty has had a yearlong cooperation with the Danish Shareholders’ Association and has represented damaged investors in the Amagerbanken and Pandora litigations.
  • Pomerantz LLP – An American law firm founded over 80 years ago that specializes in securities litigation and has served as lead counsel in many major cases, including as lead counsel in the Petrobras securities fraud class action in the U.S. which resulted in a USD $3 billion settlement, one of the largest shareholder settlements in US history.
  • Lieff Cabraser Heimann & Bernstein, LLP – American law firm Lieff Cabraser Heimann & Bernstein, LLP has litigated and resolved some of the most important complex civil and securities litigations in recent history, including the recent $15 billion civil settlement with Volkswagen on behalf of American diesel vehicle owners and lessees.
  • TILP Litigation Rechtsanwaltsgesellschaft mbH – The leading collective action law firm in Germany, pursuing compensation for investment losses in securities fraud cases in Germany and throughout Europe. TILP has been appointed as the law firm to represent the model plaintiff in the highly publicized Volkswagen “Dieselgate” KapMuG collective litigation proceeding in Braunschweig, Germany. TILP Litigation is litigating the Volkswagen case on behalf of international investors with damages claims in excess of EUR €9.5 billion.
  • Lemstra Van der Korst - A leading law firm in the Netherlands with vast experience representing international investors in Dutch collective litigation and global settlements law (WCAM). Lemstra has recently secured a critical jurisdiction ruling in the highly publicized group litigation in the Netherlands on behalf of damaged Petrobras investors. Lemstra Van der Korst has represented damaged international shareholders in global settlements, including the Converium and Royal Dutch Shell WCAM settlements.

Administrators, Funders, Service Providers and Consultants:

  • ISAF Management - ISAF Management Company and ISAF for Damaged Danske Investors, LLC provides international litigation research and organization focused on institutional investor objectives. ISAF interacts with investors, law firms, service providers and undertakes administrative tasks, including the collection of client trading data, loss calculations, loss certification, and most aspects of investor related litigation documentation. In addition, ISAF provides investors with transparent, cost effective contingency financing of all litigation costs.
  • Battea Class Action Services – Battea Class Action Services, LLC, an international leader and expert in the class action securities processing and claims filing space, has been retained to securely collect, store and process client data and validate each investor’s loss calculations, to be included in the collective Group loss claims.
  • U.S. Market Advisors Law Group PLLC – An American law firm that provides professional services to leading national and global law firms in matters involving financial markets trading, economic modeling, market structure understanding, research and transaction analysis.

Eligible investors who wish to participate in the Group litigation referenced above must proactively join the ISAF litigation Group prior to the filing of the complaint with the Danish Court. The writ of summons will be filed in the first quarter of 2019. Investors who experienced losses must contact ISAF so that eligibility can be verified and claims can be properly registered with the Court.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

LEGAL AND RELATED MEDIA INQUIRIES:
Németh Sigetty
Ole Sigetty +4533133344
os@nslaw.dk
INVESTOR AND RELATED MEDIA INQUIRIES:
ISAF Management Company
Adam Foulke, +1-203-252-3378
afoulke@isafmanagement.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye